VAISHALI PHARMA
Back to Balance Sheet
|
VAISHALI PHARMA Last 5 Year Total Non-Current Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹3.86 Cr | ₹6.16 Cr | ₹3.17 Cr | ₹4.30 Cr | ₹4.28 Cr |
What is the latest Total Non-Current Liabilities ratio of VAISHALI PHARMA ?
Year | Total Non-Current Liabilities |
---|---|
Mar2024 | ₹3.86 Cr |
Mar2023 | ₹6.16 Cr |
Mar2022 | ₹3.17 Cr |
Mar2021 | ₹4.30 Cr |
Mar2020 | ₹4.28 Cr |
How is Total Non-Current Liabilities of VAISHALI PHARMA Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹3.86 Cr | -37.30 | |
Mar2023 | ₹6.16 Cr | 94.04 | |
Mar2022 | ₹3.17 Cr | -26.16 | |
Mar2021 | ₹4.30 Cr | 0.30 | |
Mar2020 | ₹4.28 Cr | - |
Compare Total Non-Current Liabilities of peers of VAISHALI PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
VAISHALI PHARMA | ₹166.6 Cr | 2.4% | 2.1% | -17.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹406,267.0 Cr | 0.7% | 2.8% | 7.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹178,672.0 Cr | -0.8% | 3.7% | 48.6% | Stock Analytics | |
CIPLA | ₹119,713.0 Cr | -0.2% | -0.1% | -1.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹119,195.0 Cr | 3.4% | 11.2% | 17.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,999.0 Cr | 0.6% | -5.2% | -4.9% | Stock Analytics |
VAISHALI PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
VAISHALI PHARMA | 2.4% |
2.1% |
-17.2% |
SENSEX | -0.9% |
0.4% |
1.4% |
You may also like the below Video Courses